On the heels of FDA sending out a tranche of warning letters to sellers of cannabidiol (CBD) products, enterprising plaintiffs lawyers have filed a spate of consumer class actions over these types of products. The complaints put forth a number of different theories tied to the current illegality of these products due to FDA regulation. These include allegations that companies:
- misled consumers by marketing their products as dietary supplements,
- inaccurately listed CBD dosages or product content; and
- made unsubstantiated claims about CBD’s ability to treat, prevent, or cure human disease.
Is it worth the risk?
Hemp-derived CBD was legalized in … Continue Reading